These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 20682849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
    Francois A, Kerckhove N, Meleine M, Alloui A, Barrere C, Gelot A, Uebele VN, Renger JJ, Eschalier A, Ardid D, Bourinet E.
    Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
    [Abstract] [Full Text] [Related]

  • 3. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
    Cazade M, Nuss CE, Bidaud I, Renger JJ, Uebele VN, Lory P, Chemin J.
    Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
    Abbadie C, McManus OB, Sun SY, Bugianesi RM, Dai G, Haedo RJ, Herrington JB, Kaczorowski GJ, Smith MM, Swensen AM, Warren VA, Williams B, Arneric SP, Eduljee C, Snutch TP, Tringham EW, Jochnowitz N, Liang A, Euan MacIntyre D, McGowan E, Mistry S, White VV, Hoyt SB, London C, Lyons KA, Bunting PB, Volksdorf S, Duffy JL.
    J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.
    Cataldi M, Lariccia V, Marzaioli V, Cavaccini A, Curia G, Viggiano D, Canzoniero LM, di Renzo G, Avoli M, Annunziato L.
    J Neurophysiol; 2007 Oct; 98(4):2274-84. PubMed ID: 17699699
    [Abstract] [Full Text] [Related]

  • 13. CSTX-1, a toxin from the venom of the hunting spider Cupiennius salei, is a selective blocker of L-type calcium channels in mammalian neurons.
    Kubista H, Mafra RA, Chong Y, Nicholson GM, Beirão PS, Cruz JS, Boehm S, Nentwig W, Kuhn-Nentwig L.
    Neuropharmacology; 2007 Jun; 52(8):1650-62. PubMed ID: 17517422
    [Abstract] [Full Text] [Related]

  • 14. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G, Motin L, Haythornthwaite A, Vink S, Bansal P, Drinkwater R, Wang CI, Moretta M, Lewis RJ, Alewood PF, Christie MJ, Adams DJ.
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [Abstract] [Full Text] [Related]

  • 15. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
    Todorovic SM, Pathirathna S, Brimelow BC, Jagodic MM, Ko SH, Jiang X, Nilsson KR, Zorumski CF, Covey DF, Jevtovic-Todorovic V.
    Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
    [Abstract] [Full Text] [Related]

  • 16. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
    Sakkaki S, Gangarossa G, Lerat B, Françon D, Forichon L, Chemin J, Valjent E, Lerner-Natoli M, Lory P.
    Neuropharmacology; 2016 Feb; 101():320-9. PubMed ID: 26456350
    [Abstract] [Full Text] [Related]

  • 17. Actions of U-92032, a T-type Ca2+ channel antagonist, support a functional linkage between I(T) and slow intrathalamic rhythms.
    Porcello DM, Smith SD, Huguenard JR.
    J Neurophysiol; 2003 Jan; 89(1):177-85. PubMed ID: 12522170
    [Abstract] [Full Text] [Related]

  • 18. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):424-34. PubMed ID: 18331727
    [Abstract] [Full Text] [Related]

  • 19. Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent.
    Trezise DJ, John VH, Xie XM.
    Br J Pharmacol; 1998 Jul 28; 124(5):953-63. PubMed ID: 9692781
    [Abstract] [Full Text] [Related]

  • 20. Modulation of native T-type calcium channels by omega-3 fatty acids.
    Danthi SJ, Enyeart JA, Enyeart JJ.
    Biochem Biophys Res Commun; 2005 Feb 11; 327(2):485-93. PubMed ID: 15629140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.